期刊文献+

采用产氨短杆菌合成辅酶A的研究 被引量:4

STUDIES ON CoA SYNTHESIZED BY BREVIBACTERIUM AMMONIAGENES
下载PDF
导出
摘要 用产氨短杆菌鲜菌体在以腺嘌呤代替ATP的反应系统中酶促合成辅酶A(CoA),每毫升反应液的 CoA 产量达221单位(u);在不加任何核苷酸类物质的条件下,也可达185u;合成在5小时左右达高峰。CoA 合成主要在细胞内进行。提出了连续式碳-阴离子交换树脂柱提纯CoA 的新方法,既提高了收率,又避免了原锌汞齐法的毒物危害,方法简易可行。用本法制得的结晶品含 CoA 231u/mg,收率17.0%;阴柱洗脱液不经结晶直接制成 CoA 注射液,提取率20.9%,经广州药检所检验,各项指标均符合国家标准。 CoA was enzymatically synthesized by Brevibacterium ammoniagenes,using adenine inplace of ATP as a precursor.The amount of synthesizing CoA was 221 units in every milliterfor the reaction mixture.If no adenine was used in the CoA synthesis reaction system,theamount of synthesizing CoA was as high as 185 units per milliliter.The optimum time of syn-thesizing CoA was about 5h.CoA was mainly formed inside the bacterial cell.We had pro-vided a new process of purifying CoA by a series of columns involving carbon and anion ex-change resin.The process not only increased the yield of CoA,but also avoided the poisonfrom applying the Zn-Hg amalgamation process.It also simplified the operation.Crystal CoA obtained by this new method contained CoA 231 units per milligram,andthe yield was 17.0 percent.If final CoA elution was directly collected,the yield could be rai-sed to 20.9 percent.
出处 《微生物学报》 CAS CSCD 北大核心 1993年第1期32-39,共8页 Acta Microbiologica Sinica
关键词 辅酶A 产氨短杆菌 Coenzyme A Brevibacterium ammoniagenes
  • 相关文献

参考文献3

  • 1丁兆坤,广东生化通讯,1985年,2卷,3期,86页
  • 2团体著者,上海市药品检验标准,1974年
  • 3团体著者,常用数理统计方法,1973年

同被引文献18

  • 1陈泽芳,黄光琳,汪定江.固定化微生物细胞合成辅酶A的初步研究[J].医药工业,1988(1):13-16. 被引量:3
  • 2Binaghi P, Cellina G, Locicero G, et al. Evaluation of the cholesterol-lowering effectiveness of pantethine in women in perimenopausal age[J]. Minerva Med, 1990, 81 (6) : 475--479.
  • 3陈琼华.生物化学[M].北京:人民卫生出版社,1985:131-132.
  • 4Carrara P, Matturri L, Galbusse M, et al. Pantethine reduces plasma cholesterol and the severity of arterial lesion in experimental hyprcholesterolemic rabbits[J]. Atherosclerosis, 1984, 53 (3) : 255--264.
  • 5Cighetti G, Delpuppo M, Paroni R, et al. Pantethine inhibits scholesterol and fatty acid syntheses and stimulates carbon dioxide formulation in isolated rat hepatocytes[J]. JLipidRes, 1987, 28 (2) : 152--161.
  • 6Oseno Y, Hirose N, Nakajima K, et al. The effect of pantethine on fatty liver and fat distribution[J]. J Aatherascler Thromb, 2000, 7 ( 1 ) : 55--58.
  • 7Arsenio L, Boddria P, Mngnati G, et al. Effectiveness of long-term treatment with pantethine in patients with dyslipidemia [J]. Clin Ther, 1986, 8 (5) .. 537--545.
  • 8Prisco D, Rogasi P G, Matucci M, et al. Effect of oral treatment with pantethine on platelet and plasma phospholipid in IIA hyperlipoproteinemia[J]. Anglology, 1987, 38 (3) : 241--247.
  • 9Eto M, Watanabe K, Chonan N, et al. Lowering effect of pantethine on plasma beta-thrombglobin and lipids in diabetes mellitus[J]. Artery, 1987, 15 (1) : 1-- 12.
  • 10Coronel F, Tomero F, Tormnte J, et al. Treatment of hyperlipimia in diabetic patients on dialysis with a physiological substance[J]. Am Nephrol, 1991, 11 ( 1 ) : 32--36.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部